NasdaqGS - Nasdaq Real Time Price
USD
Recursion Pharmaceuticals, Inc. (RXRX)
3.5200
+0.0200
(+0.57%)
At close: November 6 at 4:00:00 PM EST
3.5278
+0.0078
(+0.22%)
After hours: November 6 at 7:59:37 PM EST
Trade RXRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreAnalyst Insights
Top Analyst
Needham
47/100
Analyst Price Targets
Analyst Recommendations
-
Strong Buy
-
Buy
-
Hold
-
Underperform
-
Sell
Latest Rating
Date
10/19/2026
Analyst
Needham
Rating Action
Reiterates
Rating
Buy
Price Action
Maintains
Price Target
8 -> 8
Top Analysts
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more
Yahoo Finance’s Top Analysts section provides an objective scorecard to evaluate the accuracy of Wall Street analyst ratings and price targets.
Learn more| Analyst
|
Overall Score
|
Direction Score
|
Price Score
|
Latest Rating
|
Price Target
|
Date
|
|---|---|---|---|---|---|---|
|
Needham
|
47 | 23 | 98 | Buy
|
8 | 2026-10-20 |
|
Morgan Stanley
|
45 | 29 | 99 | Equal-Weight
|
5.5 | 2026-05-14 |
Rows per page
1-2 of 2
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 10/19/2026 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 5/14/2026 |
| Reiterates | Needham: Buy to Buy | 5/7/2026 |
| Maintains | JP Morgan: Overweight to Overweight | 4/30/2026 |
| Maintains | B of A Securities: Neutral to Neutral | 2/26/2026 |
| Reiterates | Needham: Buy to Buy | 2/26/2026 |
